Warby Parker Inc (WRBY) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Warby Parker Inc stock (WRBY) is currently trading at $23.38. Warby Parker Inc PE ratio is 2269.00. Warby Parker Inc PS ratio (Price-to-Sales) is 3.19. Analyst consensus price target for WRBY is $29.17. WallStSmart rates WRBY as Sell.
- WRBY PE ratio analysis and historical PE chart
- WRBY PS ratio (Price-to-Sales) history and trend
- WRBY intrinsic value — DCF, Graham Number, EPV models
- WRBY stock price prediction 2025 2026 2027 2028 2029 2030
- WRBY fair value vs current price
- WRBY insider transactions and insider buying
- Is WRBY undervalued or overvalued?
- Warby Parker Inc financial analysis — revenue, earnings, cash flow
- WRBY Piotroski F-Score and Altman Z-Score
- WRBY analyst price target and Smart Rating
Warby Parker Inc
📊 No data available
Try selecting a different time range
WRBY Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Warby Parker Inc (WRBY)
WRBY trades 31314% above its Graham fair value of $0.07, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Warby Parker Inc (WRBY) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Warby Parker Inc (WRBY) Key Strengths (2)
102.18% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Warby Parker Inc (WRBY) Areas to Watch (6)
Losing money on operations
Very low returns on shareholder equity
Very expensive at 7.6x book value
Very thin margins, barely profitable
Revenue is fairly priced at 3.19x sales
Solid revenue growth at 11.20% per year
Supporting Valuation Data
Warby Parker Inc (WRBY) Detailed Analysis Report
Overall Assessment
This company scores 32/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 8.5/10) while 6 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap.
The Bear Case
The primary concerns are Operating Margin, Return on Equity, Price/Book. Some valuation metrics including Price/Sales (3.19), Price/Book (7.56) suggest expensive pricing. Growth concerns include Revenue Growth at 11.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 0.46%, Operating Margin at -4.54%, Profit Margin at 0.19%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 0.46% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 11.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
WRBY Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
WRBY's Price-to-Sales ratio of 3.19x sits near its historical average of 3.51x (61th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 78% below its historical high of 14.5x set in Oct 2021, and 71% above its historical low of 1.86x in Apr 2023. Over the past 12 months, the PS ratio has expanded from ~2.6x, reflecting growing market expectations outpacing revenue growth.
Compare WRBY with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Warby Parker Inc (WRBY) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Warby Parker Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 872M with 11% growth year-over-year. Profit margins are thin at 0.2%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 8M in free cash flow and 23M in operating cash flow. Earnings are translating into actual cash generation.
ROE of 0.5% suggests the company isn't efficiently converting equity into profits.
What to Watch Next
Margin expansion: can Warby Parker Inc push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 2269.0x. Any growth miss could trigger a sharp correction.
Volatility is elevated with a beta of 2.06, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Warby Parker Inc.
Bottom Line
Warby Parker Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Warby Parker Inc(WRBY)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Warby Parker Inc. is an innovative leader in the direct-to-consumer eyewear market, redefining the optical landscape since its founding in 2010. By seamlessly blending a robust online platform with a growing number of physical retail outlets, the company enhances customer engagement while maintaining a focus on stylish, affordable prescription eyewear and sunglasses. Warby Parker's commitment to social impact is exemplified by its "Buy a Pair, Give a Pair" initiative, which fosters community support by providing eyewear to those in need. With a unique brand identity and forward-thinking marketing strategies, Warby Parker is well-positioned for continued expansion and enduring success in the competitive eyewear industry.